Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies

Clin Microbiol Infect. 2022 Jul;28(7):1037-1039. doi: 10.1016/j.cmi.2022.03.005. Epub 2022 Mar 15.

¹ Department of Medical Biotechnologies, University of Siena, Siena, Italy.
² Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
³ Laboratory of Clinical Microbiology, Virology and Bioemergencies ASST Fatebenefratelli Sacco L. Sacco Hospital, Milan, Italy.
⁴ Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
⁵ Infectious Disease Department, USL SUDEST, Misericordia Hospital, Toscana, Grosseto, Italy.
⁶ Department of Medical Biotechnologies, University of Siena, Siena, Italy. Electronic address: vicenti@unisi.it.

No abstract available

Publication types